Pharmacokinetics and systemic β 2-adrenoceptor-mediated responses to inhaled salbutamol

British Journal of Clinical Pharmacology

Volumn 51, Issue 4, 2001, Pages 359-362

  Fowler, Stephen J ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

2 adrenoceptor; Pharmacokinetics; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; POTASSIUM;

ARTICLE; DEVICE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYPOKALEMIA; NORMAL HUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TACHYCARDIA; TREMOR; ADULT; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART RATE; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HEART RATE; HUMANS; LUNG; POTASSIUM; REGRESSION ANALYSIS; TREMOR;

EID: 0034744456     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.01362.x     Document Type: Article

References (16)

1. Pharmacokinetics of inhaled drugs
2. Dose-response of inhaled drugs in asthma
3. Lung bioavailability of generic and innovator salbutamol metered dose inhalers
4. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device
5. Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small Volume antistatic metal spacer (Airomir CFC-free MDI plus Nebuchamber)
6. Lung delivery of salbutamol given by breath activated pressurised aerosol and dry powder inhaler devices
7. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol
8. Lung delivery of non-CFC salbutamol via small Volume metal spacer and large Volume plastic spacer devices compared with an open vent jet nebuliser
9. Early lung absorption profile of non-CFC salbutamol via small and large Volume plastic spacer devices
10. Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices
11. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects
12. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma
13. 2-receptors in the human heart
14. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propanolol, practolol and atropine
15. Lung bioavailability of generic and innovator salbutamol MDIs
16. Effects of airway calibre on lung delivery of nebulised salbutamol